CLINICAL_TRIALS
trial_result
· 2010-10-01
Clinical Trial Update: Ibodutant for Relief of Irritable Bowel Syndrome (IRIS) [Phase 2]
Summary
Phase 2 clinical trial update for ibodutant evaluating relief of irritable bowel syndrome; results from the IRIS trial were posted in October 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Menarini Group | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-10-01